Erschienen in:
01.05.2004 | Brief Report
Rapid detection of Mycoplasma pneumoniae IgM antibodies in pediatric patients using ImmunoCard Mycoplasma compared to conventional enzyme immunoassays
verfasst von:
J. J. Dunn, A. K. Malan, J. Evans, C. M. Litwin
Erschienen in:
European Journal of Clinical Microbiology & Infectious Diseases
|
Ausgabe 5/2004
Einloggen, um Zugang zu erhalten
Excerpt
Mycoplasma pneumoniae is a common cause of community-acquired respiratory infection in children. An estimated 30% of
Mycoplasma pneumoniae infections in those 5–15 years of age result in pneumonia and, overall,
Mycoplasma pneumoniae is responsible for 10–40% of all cases of community-acquired pneumonia in children [
1,
2]. A specific diagnosis of
Mycoplasma pneumoniae infection is important since treatment with routinely used β-lactam antibiotics is ineffective against these organisms which lack a cell wall. Proper treatment of infected patients with macrolide antibiotics shortens the duration of overt infection and decreases the severity of respiratory symptoms [
2,
3]. Unfortunately, the prompt and accurate diagnosis of
Mycoplasma pneumoniae infection in children is hampered by the lack of standardized, rapid, and specific testing methods. …